<?xml version="1.0" encoding="UTF-8"?>
<item xmlns="http://omeka.org/schemas/omeka-xml/v5" itemId="6028" public="1" featured="0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="http://exhibits.library.stonybrook.edu/mfp/items/show/6028?output=omeka-xml" accessDate="2026-06-07T19:15:03+00:00">
  <fileContainer>
    <file fileId="6351">
      <src>http://exhibits.library.stonybrook.edu/mfp/files/original/965ac56cb625a1364d394f00e7f4693a.pdf</src>
      <authentication>366544eacb662052e3aad6ee3546ad7d</authentication>
      <elementSetContainer>
        <elementSet elementSetId="4">
          <name>PDF Text</name>
          <description/>
          <elementContainer>
            <element elementId="52">
              <name>Text</name>
              <description/>
              <elementTextContainer>
                <elementText elementTextId="106958">
                  <text>November 20, 197h

E. N. Terry,

M.

D.

Medical Director
Pharme Research (Canada) Ltd.
250 Hymns Boulevard

Points Claire, P.Q., Canada
Dear

Stitch,
I was pleased to review the data for the

compound

Si 93.

The volume consisted of three parts: pharmacology and toxicology,
dated 19 August 1970; clinical pilot studies dated November 2, 1972;
and psychometric studies dated June 17. l97h.
:m—

wmw-ww

The pharmacologic evidence indicates that Si 93 is atropine—
like with tachycardia, mydrinsis, and dry mouth as predominant symytons.
It is readily absorbed and at high doses inhibits gastric secretion.
The anticholinergic actibity was also manifest in EEG studies-in
rabbits and cats where 81 93 exhibited atropine-like patterns. The

anticholinergic activity suggested

its

use as a spasmolytic.

In the clinical studies, the dose range is defined. At
there were no effects. At ho mg. anticholinergic and sedation
occurred. At 60 mg, the subjects complained of fatigue and drowsi5 mg,

.

&lt;

ness in addition to the anticholinergic effects. In a crossover
controlled study of 25 ng and 50 mg Si 93, the differences between
the two doses were small with greater changes in pulse rate for the
25 mg dose.

«luv-v

nun-m

nu-~4-uexlrw-mu—wxrﬂ

g
m...

.m—v

v“

mwn.mrv'ﬂil‘ﬂrr”"

,‘I'VIVFIE

—'vr‘4

—v

test data reportﬂ’interesting findings.
Eight volunteers were seen in a double-blind crossoveg;gtndy of
SI 93 Ild25 mg and 50 mg, oxasepen 20 mgI'IE’E'EOnparison substance,
and placebo. The 50 mg dose of Si 93 elicited greater sedation than
20 mg oxasepan. but also an inner "stimulation". irritability, unpleasantness. feelings of warmth, and some clouding of sensorium.
The 25 mg dose of Si 93 vss found to be pleasant and equivalent to
The psychometric

oxssepan.

�,valnlrm...“ VW'K‘:"F .,

)

;

___.-

er.

,

.
y'vsc. .Y.. _new-m.,.. a._ “wees—w'cv a .&gt;.. W2...”,

.Inﬁu-VHW .“m-v.

V

V

mm “4’".'—'
v

—

-

~ V--

~

'3

1-

.
sn-Mr-w

rv-mww

»

4-,“ w -m n.

—

»

e.

LF—IGY‘
,, wan-VB;w-:’atv4‘lr:'t¢:gr:aw{v-a

.

‘

/

4

E. N. Terry, 14.1).

-2-

November 20, 197k

These observations strongly suggest that 81 93 has central
at
activity the doses studied; that the activity is pleasant and
'tranuillisina' at low doses, but unpleasant at high; that there
a relatively narrow therapeutic range, for the 50 mg dose elicits is
'some of the central deliriant effects of the
anticholinergics. There

are

interesting questions about the compound:
Are the central effects similar to oxasepam (and other
benzodiacepines). or like imipramine (ditran, and other thymoleptics)?
some

‘Does 86 93 have a

at lower doses,

diphasic effect—~sedative and pleasant
deliriant at higher doses?

and stimulant and

These questions can be answered by our present methods or
electrophysiologic assay, for a classification study will define the
Atype of central activity in man and yield evidence of its
therapeutic
range; and a dose-ranging study will give data for the stability or the
nature of the central effects.
'

However, the questions that must be answered by management
before these studies are undertaken seem to me to be: Is there a need
for a novel thymoleptic; and it there is, can 81 93 quality for further
study since it may have a narrow therapeutic range?

If

the answer is affirmative and further studies are desired,
to examine this compound. For a dose—finding study,
single doses of 5.10.20, he and 60 mg should be examined. FOr a classi~
fication study, two doses and placebo could be examined in 10-12 sub-~
Jects over a post-drug four hour period with measurement of EEG, alert.
ness, heart rate, blood pressure, mood ratings, symptom ratings, and
critical flicker fusion (CFF). and the observations compared with our
historical standard? diasepam and imipramine.
we

would be pleased

my

thanks {hr the opportunity to review these data in

It

seems

to be an interesting centrally active

originals.{

My

compound.

their

German

.

best regards.
Sincerely yours,
Fink, M. D.
Professor of Psychiatry
Max

Merd

Again.

“ah-

.7

�</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </file>
  </fileContainer>
  <collection collectionId="1">
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="1">
                <text>Correspondence</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </collection>
  <itemType itemTypeId="1">
    <name>Text</name>
    <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
  </itemType>
  <elementSetContainer>
    <elementSet elementSetId="1">
      <name>Dublin Core</name>
      <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
      <elementContainer>
        <element elementId="50">
          <name>Title</name>
          <description>A name given to the resource</description>
          <elementTextContainer>
            <elementText elementTextId="60274">
              <text>Correspondence to: Zimmerman, Kimblerly</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="51">
          <name>Type</name>
          <description>The nature or genre of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="60275">
              <text>Text</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="43">
          <name>Identifier</name>
          <description>An unambiguous reference to the resource within a given context</description>
          <elementTextContainer>
            <elementText elementTextId="60276">
              <text>mfp-05-00-027-8-574</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="40">
          <name>Date</name>
          <description>A point or period of time associated with an event in the lifecycle of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="60277">
              <text>1974 </text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="39">
          <name>Creator</name>
          <description>An entity primarily responsible for making the resource</description>
          <elementTextContainer>
            <elementText elementTextId="60278">
              <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="49">
          <name>Subject</name>
          <description>The topic of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="60279">
              <text>Correspondence -- Correspondence</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="46">
          <name>Relation</name>
          <description>A related resource</description>
          <elementTextContainer>
            <elementText elementTextId="60280">
              <text>The Max Fink Collection</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="41">
          <name>Description</name>
          <description>An account of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="60281">
              <text/>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="47">
          <name>Rights</name>
          <description>Information about rights held in and over the resource</description>
          <elementTextContainer>
            <elementText elementTextId="60282">
              <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="48">
          <name>Source</name>
          <description>A related resource from which the described resource is derived</description>
          <elementTextContainer>
            <elementText elementTextId="60283">
              <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="44">
          <name>Language</name>
          <description>A language of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="80230">
              <text>en-US</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="42">
          <name>Format</name>
          <description>The file format, physical medium, or dimensions of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="86791">
              <text>application/pdf</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="45">
          <name>Publisher</name>
          <description>An entity responsible for making the resource available</description>
          <elementTextContainer>
            <elementText elementTextId="93352">
              <text/>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="37">
          <name>Contributor</name>
          <description>An entity responsible for making contributions to the resource</description>
          <elementTextContainer>
            <elementText elementTextId="99913">
              <text/>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </elementSet>
  </elementSetContainer>
  <tagContainer>
    <tag tagId="4">
      <name>Correspondence</name>
    </tag>
  </tagContainer>
</item>
